TT-816 As Monotherapy or in Combination with a PD-1 Inhibitor in Patients with Advanced Cancers (SEABEAM) (MK3475-E88)
Clinical trial NCT05525455 · TERMINATED
Trial details
- NCT number
- NCT05525455
- Sponsor
- Teon Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-29
- Primary completion
- 2023-09-07
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.